(Q51901667)

17 April 2018

title

Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups. (English)

1 reference

17 April 2018

diffuse large B-cell lymphoma

1 reference

1 reference

1 reference

4

1 reference

17 April 2018

author name string

Lene Dissing Sjö

1

1 reference

17 April 2018

Christian Bjørn Poulsen

2

1 reference

17 April 2018

Mads Hansen

3

1 reference

17 April 2018

Elisabeth Ralfkiaer

5

1 reference

17 April 2018

publication date

7 November 2007

1 reference

17 April 2018

European Journal of Haematology

published in

1 reference

17 April 2018

volume

79

1 reference

17 April 2018

issue

6

1 reference

17 April 2018

page(s)

501-507

1 reference

17 April 2018

describes a project that uses

1 reference

Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Microarray-based classification of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Prognostic biomarkers in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

Prognostic significance of metallothionein in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00976.X

10.1111/J.1600-0609.2007.00976.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

17986209

1 reference

17 April 2018